CP-10 is primarily used in the field of immunology and biomedical research. It serves as a potent chemokine receptor antagonist, specifically targeting the CCR1 receptor. This makes it valuable in studying inflammatory processes and immune responses. Researchers utilize CP-10 to investigate its potential in treating autoimmune diseases, such as rheumatoid arthritis and multiple sclerosis, by inhibiting the migration of inflammatory cells to affected tissues. Additionally, it is employed in preclinical studies to explore its efficacy in reducing inflammation in various disease models. Its application extends to drug development, where it aids in the design of novel therapeutic agents targeting chemokine-mediated pathways.